950 TOWER LANE, SUITE 1050, FOSTER CITY, CA
Election of Directors at Mirum Pharmaceuticals Annual Meeting
Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes
Other Events
Annual Report to Security Holders
Amended material disclosure
Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities